TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Clinical trial NCT04306900 · COMPLETED
Trial details
- NCT number
- NCT04306900
- Sponsor
- Trishula Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-30
- Primary completion
- 2022-11-30
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.